Dr Reddy’s Laboratories Wins FDA Approval for HIV Shot

Dr Reddy’s Laboratories has received tentative approval from the US FDA for its twice-a-year HIV prevention shot, lenacapavir. This long-acting injectable aims to help people stay safe from HIV without the hassle of daily pills. With support from partners, Dr Reddy’s is preparing to make this innovative option available in 120 countries by 2027.